Literature DB >> 18406575

Clinical usefulness of tissue Doppler imaging in patients with mild to moderate aortic stenosis: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin study.

Davinder S Jassal1, James W Tam, Jean G Dumesnil, Peter J Giannoccaro, John Jue, A Shekhar Pandey, Campbell D Joyner, Koon K Teo, Kwan L Chan.   

Abstract

OBJECTIVE: Although impaired diastolic function is common in aortic stenosis (AS), little is known about the clinical usefulness of tissue Doppler imaging (TDI) to detect diastolic dysfunction in patients with mild to moderate AS. The objective was to describe both conventional and TDI measurements of diastolic function in asymptomatic patients enrolled in the Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin study, a multicenter study to assess the effect of rosuvastatin on the progression of AS.
METHODS: Baseline echocardiography measurements, including left ventricular interventricular septal thickness, posterior wall thickness, cavity dimensions, and ejection fraction were obtained. Conventional Doppler indices, including peak early (E) and late (A) transmitral velocities, E/A ratio, and E-wave deceleration time, were measured from spectral Doppler. Tissue Doppler measurements, including early (E') and late (A') velocities of the lateral annulus, were determined, and E/E' was calculated.
RESULTS: The study population included 172 patients (aged 57 +/- 13 years; 73 were female) divided into three categories of AS severity on the basis of peak velocity at baseline (group I: 2.5-3.0 m/s; group II: 3.1-3.5 m/s; group III; 3.6-4.0 m/s). Baseline hemodynamics, left ventricular dimensions, and conventional diastolic functional parameters were similar among all 3 groups. In patients with greater severity of AS, the lateral E' was lower and the E/E' (as an estimate of increased left ventricular end-diastolic pressure) was higher (P <.05).
CONCLUSION: In patients with mild to moderate asymptomatic AS, TDI measures of diastolic function are abnormal and related to the severity of AS. These findings may help to predict the future development of symptoms in this population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18406575     DOI: 10.1016/j.echo.2008.02.014

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  6 in total

1.  Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis.

Authors:  Luis M Moura; Susana Faria; Miguel Brito; Fausto J Pinto; Steen D Kristensen; Isabel M Barros; Nalini Rajamannan; Francisco Rocha-Gonçalves
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

2.  Postnatal left ventricular diastolic function after fetal aortic valvuloplasty.

Authors:  Kevin G Friedman; Renee Margossian; Dionne A Graham; David M Harrild; Sitaram M Emani; Louise E Wilkins-Haug; Doff B McElhinney; Wayne Tworetzky
Journal:  Am J Cardiol       Date:  2011-05-31       Impact factor: 2.778

Review 3.  Lipid-lowering efficacy of rosuvastatin.

Authors:  Stephen P Adams; Sarpreet S Sekhon; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2014-11-21

4.  Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.

Authors:  Davinder S Jassal; Kapil M Bhagirath; Erin Karlstedt; Matthew Zeglinski; Jean G Dumesnil; Koon K Teo; James W Tam; Kwan L Chan
Journal:  Cardiovasc Ultrasound       Date:  2011-02-07       Impact factor: 2.062

5.  Peri-operative changes in diastolic function and outcomes in congenital aortic valve surgery.

Authors:  Meredith Pesce; Damien LaPar; David Kalfa; Emile Bacha; Lindsay Freud
Journal:  Echocardiography       Date:  2022-01-11       Impact factor: 1.874

Review 6.  Moderate Aortic Stenosis: What is it and When Should We Intervene?

Authors:  Sveeta Badiani; Sanjeev Bhattacharyya; Nikoo Aziminia; Thomas A Treibel; Guy Lloyd
Journal:  Interv Cardiol       Date:  2021-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.